Advisory Board reports massive jump in income despite tumultuous first quarter

D.C.-based The Advisory Board Co. saw its share price jump Friday after reporting a 90 percent year-over-year increase in first-quarter net income, beating analyst expectations. The improved margins come after the health and education consultancy embarked on a cost-cutting mission, resulting in $11.2 million in restructuring-related charges. Advisory Board also reported a $23.4 million gain from selling Evolent Health stock during the quarter. For the first quarter, Advis ory Board (NASDAQ: ABCO)…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news